Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal.

Also, compared to patients without diabetes, patients with uncomplicated or complicated diabetes had a 10–11% higher risk of colorectal cancer recurrence.

In patients with type 2 diabetes, GLP-1 agonist therapy is associated with decreased risk for AF recurrence following ablation for AF.